Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Line item | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|
| Proceeds from financial royalty assets | 9,500 | 5,179 |
| Purchases of derivatives | (2,672) | (7,620) |
| Proceeds from sale of derivatives | 1,045 | — |
| Purchases of property and equipment | (254) | (428) |
| Purchases of short-term investments | (259,327) | (122,717) |
| Proceeds from sale of short-term investments | 242,563 | 38,414 |
| Proceeds from maturity of short-term investments | 239,805 | 83,220 |
| Purchases of other investments | (1,250) | — |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's capex?
- Ligand Pharmaceuticals (LGND) reported capex of $26K in Q2 2026.
- How has Ligand Pharmaceuticals's capex changed year-over-year?
- Ligand Pharmaceuticals's capex decreased by 87.9% year-over-year, from $214K to $26K.
- What is the long-term trend for Ligand Pharmaceuticals's capex?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's capex has grown at a -52.3% compound annual growth rate (CAGR), from $8.76M to $452K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Ligand Pharmaceuticals's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude